Neptune Wellness Solutions (NEPT) Stock Price, News & Analysis

Company Overview

Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.20 to $0.55
• 52-Week Range: N/A
• Volume: 2.25 million shs
• Average Volume: 462,687 shs
• Market Capitalization: $906,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NEPT Stock Analysis - Frequently Asked Questions

How were Neptune Wellness Solutions' earnings last quarter?

Neptune Wellness Solutions Inc (NASDAQ:NEPT) announced its quarterly earnings results on Friday, August, 18th. The biotechnology company reported ($12.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($11.20) by $0.80. The biotechnology company had revenue of $10.63 million for the quarter, compared to analysts' expectations of $10.65 million.

When did Neptune Wellness Solutions' stock split?

Shares of Neptune Wellness Solutions reverse split before market open on Friday, September 8th 2023. The 1-40 reverse split was announced on Friday, September 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Neptune Wellness Solutions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Neptune Wellness Solutions investors own include Canopy Growth (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Meta Platforms (META), Aphria (APHA), Ford Motor (F) and NVIDIA (NVDA).

Company Calendar

• Last Earnings: 8/18/2023
• Today: 11/23/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:NEPT
• CUSIP: N/A
• CIK: 1401395
• Web: www.neptunecorp.com
• Phone: 45-0687-2262
• Fax: 45-0687-2272
• Employees: 58
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($106.72)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-60,460,000.00
• Net Margins: -128.13%
• Pretax Margin: -201.55%
• Return on Equity: N/A
• Return on Assets: -141.94%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.23
• Quick Ratio: 0.10

Sales & Book Value

• Annual Sales: $52.62 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($91.90) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,530,000
• Free Float: 4,301,000
• Market Cap: $906,000.00
• Optionable: Not Optionable
• Beta: 2.19